Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Researcher Awarded $1.6 Million To Investigate Tumor Suppressor's Role In Breast Cancer
Studies have estimated that five to
generic viagra online
Work Status Changes More Common Among Women Receiving Chemotherapy For Breast Cancer, Study Says
Women with breast cancer who receive chemotherapy appear more likely than those treated with radiation therapy to experience a major change in work status, according to a study published in the journal Cancer, Reuters reports. For the study, Dana-Farber Cancer Institute researcher Michael Hassett and colleagues used a large health insurance claims database to identify 3,233 women who were first diagnosed with breast cancer between 1998 and 2002. All of the women were younger than age 64, insured, and working full time or part time as of diagnosis. About 54% of the women received chemotherapy, and 58% received radiation therapy.Hassett said that most of the women did "not experience a significant change in their employment after cancer diagnosis and treatment." However, of the 6.6% who experienced such a change, those who received chemotherapy had a 1.8-fold greater risk of leaving work, retiring or going on long-term disability leave in the subsequent year. Sixty-seven percent of women who experienced a change went from full-time employment to early retirement, while the rest went from full-time employment to long-term disability or retirement, or their status was unknown. Although the study looked at many factors, only chemotherapy and older age were associated with an increased likelihood of a change in employment. Hassett said that most of the participants in the study worked for large employers that offered health insurance. He added that further research is needed to evaluate the effect of cancer diagnosis and treatment on work status for women who are self-employed or work for smaller companies (Hendry, Reuters, 6/30).
News of the day
IBM And EU Partners Create A Better Way To Fight AIDS Virus
IBM (NYSE: IBM) today announced it was selected for its contributions to the EuResist research project for AIDS treatment as a Computerworld Honors Program Laureate for 2009.
Sexual Health

British System Highlights Cost-Effectiveness Concerns As Part Of U.S. Overhaul Effort

While Congress recently approved funds to study the cost-effectiveness of certain treatments, some are concerned that such research could lead to rationing of health care or that treatments deemed less effective will not be adequately covered, the AP/Washington Post reports. Those concerned often cite Great Britain"s National Institute for Health and Clinical Excellence, which determines which medical treatments will be covered based on cost-effectiveness. One of the criteria used by NICE to determine a treatment"s cost-effectiveness is how much each additional year of life will cost the government, which the agency has capped at about $47,000 per year of life in most cases (Cheng, AP/Washington Post, 5/26). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009